Alexander International Innovations, LLC

Alexander International Innovations, LLC, founded by CEO Damea Alexander, is an Ohio-based company dedicated to transforming healthcare through innovative medical technologies. Damea has led the company to develop cutting-edge solutions aimed at improving patient care and addressing unmet medical needs, particularly in the field of plasma-derived medications.

One of the company's key achievements is the development of I2F, a groundbreaking device designed for both human and veterinary use. I2F enhances the administration and effectiveness of plasma-derived products, and in the veterinary space, it has shown potential to revolutionize animal treatments, offering safer, more effective therapeutic options for veterinarians. This dual application highlights the company’s commitment to solving complex healthcare challenges through innovation.

Focused on pushing the boundaries of medical advancement, Alexander International Innovations strives to create sustainable, scalable healthcare solutions. With a strong emphasis on research, development, and strategic partnerships, the company continues to build its reputation as a leader in the healthcare industry, making a lasting impact through products like I2F.